Besides its important role of digestion and absorption, esophageal tissue has an essential role as a major barrier against intraluminal pathogens like hostile microorganisms and toxins. This barrier function is achieved via various mechanical, chemical, and immunological mechanisms which are typically altered in inflammatory diseases, thereby causing subsequent damage of the mucosa. In this review we will focus on the main structural and functional barriers of host defense within the esophageal mucosa, including the epithelial layer, membrane-bound and secretory mucins, and different types of defensins. In addition, we will discuss the relevance of biofilm on esophageal tissue and will illustrate the importance of different regulators of intestinal permeability like zonulin and desmosomal components.

Keywords:
Esophagus, Epithelium, Resistance, Tight junctions, Histology, Immunohistochemistry
1.
Orlando RC: Esophageal epithelial defense against acid injury. J Clin Gastroenterol 1991;2:1-5.
2.
Orlando RC: The pathogenesis of gastroesophageal reflux disease: the relationship between epithelial defense, dysmotility, and acid exposure. Am J Gastroenterol 1997;92:3-5.
3.
Orlando RC: Pathogenesis of gastroesophageal reflux disease. Am J Med Sci 2003;326:274-278.
4.
Helm JF, Dodds WJ, Pelc LR, et al: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984;310:284-288.
5.
Orr WC, Johnson LF, Robinson MG: Effect of sleep on swallowing, esophageal peristalsis, and acid clearance. Gastroenterology 1984;86:814-819.
6.
Niv Y, Fass R: The role of mucin in GERD and its complications. Nat Rev Gastroenterol Hepatol 2011;9:55-59.
7.
Fujiwara Y, Higuchi K, Tominaga K, et al: Functional oesophageal epithelial defense against acid. Inflammopharmacology 2005;13:1-13.
8.
Flemstrom G, Garner A: Gastroduodenal HCO3(-) transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 1982;242:G183-G193.
9.
Hamilton BH, Orlando RC: In vivo alkaline secretion by mammalian esophagus. Gastroenterology 1989;97:640-648.
10.
van Roon AH, Mayne GC, Wijnhoven BP, et al: Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa. J Gastrointest Surg 2008;12:1331-1340.
11.
Namiot Z, Sarosiek J, Marcinkiewicz M, et al: Declined human esophageal mucin secretion in patients with severe reflux esophagitis. Dig Dis Sci 1994;39:2523-2529.
12.
Neumann H, Mönkemüller K, Kandulski A, et al: Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis 2008;26:243-247.
13.
Khor TS, Alfaro EE, Ooi EM, et al: Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett esophagus? Am J Surg Pathol 2012;36:331-342.
14.
Piessen G, Wacrenier A, Briez N, et al: Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma. J Clin Pathol 2009;62:1144-1146.
15.
Hu Y, Jones C, Gellersen O, et al: Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg 2007;142:540-544.
16.
Lagergren J: Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005;54:1-5.
17.
Odze RD: Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 2005;100:1853-1867.
18.
Vieth M: Contribution of histology to the diagnosis of reflux disease. Best Pract Res Clin Gastroenterol 2008;22:625-638.
19.
Vieth M, Peitz U, Labenz J, et al: What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig Dis 2004;22:196-201.
20.
Vieth M, Fiocca R, Haringsma J, et al: Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesions. Dig Dis 2004;22:208-212.
21.
Orlando RC: The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol 2010;24:873-882.
22.
Orlando RC: Pathophysiology of gastroesophageal reflux disease. J Clin Gastroenterol 2008;42:584-588.
23.
Günzel D, Fromm M: Claudins and other tight junction proteins. Compr Physiol 2012;2:1819-1852.
24.
Orlando RC, Lacy ER, Tobey NA, et al: Barriers to paracellular permeability in rabbit esophageal epithelium. Gastroenterology 1992;102:910-923.
25.
Jovov B, Que J, Tobey NA, et al: Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol 2011;106:1039-1047.
26.
Wex T, Mönkemüller K, Stahr A, et al: Gastro-oesophageal reflux disease is associated with up-regulation of desmosomal components in oesophageal mucosa. Histopathology 2012;60:405-415.
27.
Tobey NA, Powell DW, Schreiner VJ, et al: Serosal bicarbonate protects against acid injury to rabbit esophagus. Gastroenterology 1989;96:1466.
28.
Tobey NA, Reddy SP, Keku TO, et al: Mechanisms of HCl-induced lowering of intracellular pH in rabbit esophageal epithelial cells. Gastroenterology 1993;105:1035.
29.
Jimenez P, Lanas A, Piazuelo E, et al: Effect of growth factors and prostaglandin E2 on restitution and proliferation of rabbit esophageal epithelial cells. Dig Dis Sci 1998;43:2309.
30.
Takahashi M, Ota S, Ogura K, et al: Hepatocyte growth factor stimulates wound repair of the rabbit esophageal epithelial cells in primary culture. Biochem Biophys Res Commun 1995;216:298.
31.
Günther C, Neumann H, Neurath MF, et al: Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 2013;62:1062-1071.
32.
Biancani P, Billett G, Hillemeier C, et al: Acute experimental esophagitis impairs signal transduction in cat lower esophageal sphincter circular muscle. Gastroenterology 1992;103:1199-1206.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.